Paper21320065
In-silico ADME models: a general assessment of their utility in drug discovery applications.
Gleeson MP and 2 others. Curr Top Med Chem, 2011. Cited by 112 papers, by iCite.
Cite this record
ConductScience Library. In-silico ADME models: a general assessment of their utility in drug discovery applications. Papers, record 21320065. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21320065
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In-silico ADME models: a general assessment of their utility in drug discovery applications.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Discovery | Major topic |
| Models, Biological | Major topic |
| Pharmaceutical Preparations | Major topic |
| Pharmacokinetics | Major topic |
| Animals | |
| Humans | |
| Metabolic Clearance Rate | |
| Predictive Value of Tests | |
| Structure-Activity Relationship |
Source PubMed
Cited by47
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40575559 | Isolation, structural elucidation, and integrated biological and computational evaluation of antidiabetic labdane diterpenes from Curcuma zedoaria rhizomes. | RSC Adv | 2025 | https://conductscience.org/library/papers/40575559 | PubMed |
| 39726044 | Comprehensive benchmarking of computational tools for predicting toxicokinetic and physicochemical properties of chemicals. | J Cheminform | 2024 | https://conductscience.org/library/papers/39726044 | PubMed |
| 38833492 | A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: Molecular docking, ADME profiling and molecular dynamics simulations. | PLoS One | 2024 | https://conductscience.org/library/papers/38833492 | PubMed |
| 38817777 | Molecular docking of curcumin and curcuminoids as human Zn+ dependent histone deacetylase (HDAC) enzyme inhibitors. | In Silico Pharmacol | 2024 | https://conductscience.org/library/papers/38817777 | PubMed |
| 38596366 | Phytochemical identification and in silico elucidation of interactions of bioactive compounds from Citrullus lanatus with androgen receptor towards prostate cancer treatment. | In Silico Pharmacol | 2024 | https://conductscience.org/library/papers/38596366 | PubMed |
| 38470555 | In-silico identification and exploration of small molecule coumarin-1,2,3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer. | Mol Divers | 2024 | https://conductscience.org/library/papers/38470555 | PubMed |
| 38434818 | Thiazolotriazoles As Anti-infectives: Design, Synthesis, Biological Evaluation and In Silico Studies. | ACS Omega | 2024 | https://conductscience.org/library/papers/38434818 | PubMed |
| 37919954 | Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer. | J Enzyme Inhib Med Chem | 2023 | https://conductscience.org/library/papers/37919954 | PubMed |
| 37908659 | Challenges in natural product-based drug discovery assisted with in silico-based methods. | RSC Adv | 2023 | https://conductscience.org/library/papers/37908659 | PubMed |
| 37893530 | Exploring Medicinal Herbs' Therapeutic Potential and Molecular Docking Analysis for Compounds as Potential Inhibitors of Human Acetylcholinesterase in Alzheimer's Disease Treatment. | Medicina (Kaunas) | 2023 | https://conductscience.org/library/papers/37893530 | PubMed |
| 37575679 | In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies. | In Silico Pharmacol | 2023 | https://conductscience.org/library/papers/37575679 | PubMed |
| 37513210 | Cytotoxicity and Genotoxicity Evaluation of Zanthoxylum rhoifolium Lam and In Silico Studies of Its Alkaloids. | Molecules | 2023 | https://conductscience.org/library/papers/37513210 | PubMed |
| 37298535 | New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298535 | PubMed |
| 37255832 | In silico docking based screening of constituents from Persian shallot as modulators of human glucokinase. | J Diabetes Metab Disord | 2023 | https://conductscience.org/library/papers/37255832 | PubMed |
| 36721524 | Synthesis of [60]Fullerene Hybrids Endowed with Steroids and Monosaccharides: Theoretical Underpinning as Promising anti-SARS-CoV-2 Agents. | European J Org Chem | 2023 | https://conductscience.org/library/papers/36721524 | PubMed |
| 36676057 | Alternative Methods as Tools for Obesity Research: In Vitro and In Silico Approaches. | Life (Basel) | 2022 | https://conductscience.org/library/papers/36676057 | PubMed |
| 36316339 | Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions. | Sci Rep | 2022 | https://conductscience.org/library/papers/36316339 | PubMed |
| 36109764 | Synthesis, biological evaluation and in-silico ADME studies of novel series of thiazolidin-2,4-dione derivatives as antimicrobial, antioxidant and anticancer agents. | BMC Chem | 2022 | https://conductscience.org/library/papers/36109764 | PubMed |
| 35479426 | Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents via carbonic anhydrase IX inhibition. | RSC Adv | 2021 | https://conductscience.org/library/papers/35479426 | PubMed |
| 35209197 | Phytochemical and In Silico ADME/Tox Analysis of Eruca sativa Extract with Antioxidant, Antibacterial and Anticancer Potential against Caco-2 and HCT-116 Colorectal Carcinoma Cell Lines. | Molecules | 2022 | https://conductscience.org/library/papers/35209197 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21320065
GET https://conductscience.org/api/papers/v1/21320065/cited_by?page=2